Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 450 results found. Search for [ United States Food and Drug Administration ]

Results 1 to 21 of 450
Reuters
April 24, 2021
We are no longer recommending a pause in the use of this vaccine, CDC Director Rochelle Walensky told a news briefing


Reuters
April 17, 2021
The United States earlier this week paused distribution of the J&J vaccine to investigate six cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), accompanied by a low blood platelet count, in U.S. women under age 50


Reuters
April 2, 2021
The US Food and Drug Administration (FDA) cleared Moderna to speed up vaccine output by letting it fill a single vial with up to 15 doses


BusinessToday.In
March 31, 2021
The companies plan to submit the data from the trial to U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of the vaccine.


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


BusinessToday.In
March 23, 2021
Stock Market News Update Today: UltraTech Cement, Titan Company, ICICI Bank, IndusInd Bank, Axis Bank were among top gainers, while ONGC, Power Grid Corporation of India, ITC, NTPC, HDFC were among top losers


Reuters
March 19, 2021
The Biden administration has come under pressure from countries around the world to share vaccines, particularly its stock of AstraZeneca's vaccine, which is authorized for use elsewhere but not yet in the United States


Reuters
March 16, 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States


BusinessToday.In
March 5, 2021
Shares of Wipro, Heranba Industries, Indiabulls Housing, Unichem Labs, Jagran Prakashan and others will be in focus in Friday's trading session


PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


PTI
March 2, 2021
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray


Reuters
March 1, 2021
Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older


PTI
February 28, 2021
The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death


BusinessToday.In
February 19, 2021
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE


BusinessToday.In
February 19, 2021
Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers


BusinessToday.In
February 12, 2021
Stock Market News Updates Today: Earlier today, Sensex hit a record high of 51,804 and Nifty hit a lifetime high of 15,243


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


BusinessToday.In
February 3, 2021
India Stock Market News Updates Today: IndusInd Bank, followed by Dr Reddy's, PowerGrid, Tech Mahindra, M&M, Sun Pharma and Axis Bank were among the top gainers. On the other hand, Maruti, Kotak Bank, SBI and UltraTech Cement were among the losers


BusinessToday.In
January 30, 2021
Coronavirus vaccine: J&J plans to seek emergency use authorisation from the US Food and Drug Administration next week. It has said it plans to deliver 1 billion doses in 2021 and will produce the vaccine in the United States, Europe, South Africa and India


Joe C Mathew
January 7, 2021
Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions


PAGES 1 OF 23  12345